Episode Details

Sam Neills cancer-free status after CAR T-cell therapy in Australia sheds light on the stark contrast between the two countries cancer care. While Australia rolls out this groundbreaking treatment in public hospitals, New Zealand lacks public funding, leaving patients with exorbitant costs or offshore options. Blood cancer is prevalent in New Zealand, with limited treatment options and long wait times, as seen in Andrew Mackintoshs experience. Neills success has sparked hope and action, with a new report and taskforce aiming to improve care and reduce disparities.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/c3a2b3e49989f267